Logos Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Biotechnology, Healthcare, Therapeutics, Medical, Pharmaceutical, Life Science, Oncology, Biopharma, Health Diagnostics, Medical Device
Stage Focus
Series B, Series C, Series D, Series A, Series E, Series G, Seed
Geographical Focus
United States, United Kingdom, Canada, Singapore, China, Denmark, Ireland
Industries Focus
- Healthcare
- Biotechnology
- Pharmaceutical
- Life Science
- Oncology
- Therapeutics
- Medical
- Biopharma
- Health Diagnostics
- Medical Device
Investment Size:
500,000 to 200,000,000 USD
Investor Details Founded: 2019
Logos Capital is a San Francisco-based venture capital firm dedicated to advancing healthcare through disciplined, data-driven investments in biotechnology. Founded in 2019, the firm combines scientific and financial expertise to identify transformative therapies in healthcare. Their approach integrates in-house data analytics with clinical trial modeling to assess the intrinsic value of each opportunity, aiming to generate superior long-term returns for investors. Logos Capital's mission is to drive groundbreaking progress in healthcare by providing the financial foundation for innovations that elevate the standard of care and improve patient lives. The firm's philosophy emphasizes a holistic approach to drug development, considering both scientific and operational aspects, and involves thorough event tracking, clinical trial underwriting, and proactive management. Their proprietary data science platform, Logos Analytics, enhances decision-making by predicting clinical trial outcomes with exceptional precision, enabling well-informed investment decisions that drive value creation.
Requirements
- Focus on transformative biotechnology companies
- Preference for companies with innovative therapeutic approaches
- Interest in both private and public biotechnology firms
- Emphasis on companies with attractive valuations
- Alignment with the firm's mission to improve patient lives
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Maze Therapeutics
- Adcendo
- 858 Therapeutics
- Third Arc Bio
- Scorpion Therapeutics
- Attovia Therapeutics
- Obsidian Therapeutics
- Mirador Therapeutics
- ProfoundBio
- Rapport Therapeutics
Mentioned In
-
$49.95
-
$14.95
-
$39.95
-
$24.95
-
$19.95
-
$24.95
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of Logos Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim